Podcasts about Endocrinology

In this episode of The Wellness Reset, we're joined by Dr. David Chandy, Director of the Department of Endocrinology at Sir H. N. Reliance Foundation Hospital with 13+ years of experience.Join us as we uncover:Why is India the Diabetes capital?The balanced plate formula to improve metabolic healthThe direct impact of stress and breathing on blood sugar levelsMounjaro & Ozempic: Safe, effective, and mindful useDoes fluctuating blood sugar levels harm your brain function?Importance of medication adherence for kidney healthImpact of air pollution and environmental chemicals on metabolic healthAnd much more…

This episode is a deep dive into the new 2026 guidelines on type 2 diabetes, applying the guidelines to various case-based scenarios. Zero to GP podcast: https://www.buzzsprout.com/2590332Zero to GP YouTube channel: https://www.youtube.com/@ZeroToGPZero to AKT course: https://zerotofinals.com/courses/zerotoakt/Books: https://zerotofinalsshop.com/

The endocrine workforce shortage is affecting the lives of endocrinologists and the patients they treat. Many practices would benefit from any support that would give endocrinologists more capacity to focus where they really need to. Could advance practice providers, such as nurse practitioners and physicians assistants, be able to provide that support if they had a little more training?   The Endocrine Society and the American Association of Nurse Practitioners? (AANP) think so. Together they have developed a new program called Clinical Advantage: Endocrinology Certificate for Advanced Practice Providers. What does the certificate represent, how does the program work?   To help answer those questions and more host Aaron Lohr talks with two guests who helped develop the program: Sara R. MacLeod, DO, MPH, Assistant Professor of Medicine at University of Rochester; and Shannon K. Idzik, DNP, CRNP, ANP-BC, FAANP, FAAN, Professor and Associate Dean for the Doctor of Nursing Practice Program at University of Maryland School of Nursing.   Listen to learn how Clinical Advantage is working to address the shortage. Show notes are available at https://www.endocrine.org/podcast

Drs Kaniksha Desai and Juan Camacho discuss thyroid artery embolization. This podcast is intended for healthcare professionals only. Kaniksha Desai, MD, Associate Professor of Medicine, Department of Endocrinology, Stanford School of Medicine, Palo Alto, California Juan C. Camacho, MD, Clinical Associate Professor, Vascular & Interventional Radiologist, Department of Clinical Sciences, Florida State University, Sarasota Memorial Hospital, Sarasota, Florida To read a transcript or to comment, visit https://www.medscape.com/index/list_15483_0

Send a textHow the body's internal circadian clocks regulate metabolism, energy balance, and health.TOPICS DISCUSSED:Master circadian clock in the brain: Light detection via retina entrains the suprachiasmatic nucleus, which coordinates body-wide rhythms; intrinsic period slightly deviates from 24 hours, allowing seasonal flexibility.Peripheral clocks in organs: Nearly all cells have autonomous clocks; liver and fat clocks rapidly adjust to feeding time, while brain clock aligns more tightly to light.Clock mutations and metabolism: Disrupting core clock genes (e.g., CLOCK, BMAL1) causes obesity, liver fat accumulation, and impaired insulin secretion without hyperinsulinemia.Timing of food intake: Eating the same high-fat calories during rest phase causes more weight gain than during active phase due to differences in energy dissipation.Modern disruptions (jet lag, shift work, blue light): Create desynchrony between brain and peripheral clocks, contributing to metabolic issues; late-night eating impairs glucose handling.Critical illness & feeding: Tube feeding at night (opposite natural cycle) induces rapid insulin resistance, highlighting mismatch costs.Hormone rhythms: Testosterone, glucocorticoids, and others peak at specific times; misalignment affects stress, reproduction, and metabolism.Weight loss drugs & maintenance: GLP-1 drugs reduce intake effectively, but regain involves neuroendocrine adaptations tied to brain clock pathways.ABOUT THE GUEST: Joseph Bass, MD, PhD is Chief of Endocrinology, Metabolism and Molecular Medicine at Northwestern University Feinberg School of Medicine, Director of the Center for Diabetes and Metabolism, and a leading researcher who pioneered the link between circadian clock genes and metabolic disorders including obesity and diabetes.RELATED EPISODE:M&M 237 | Circadian Biology: Genetics, Behavior, Metabolism, Light, Oxygen & Melatonin | Joseph TakahashiSupport the showHealth Products by M&M Partners: SporesMD: Premium mushrooms products (gourmet mushrooms, nootropics, research). Use code 'nickjikomes' for 20% off. Lumen device: Optimize your metabolism for weight loss or athletic performance. MINDMATTER gets you 15% off. AquaTru: Water filtration devices that remove microplastics, metals, bacteria, and more from your drinking water. Through link, $100 off AquaTru Carafe, Classic & Under Sink Units; $300 off Freestanding models. Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) For all the ways you can support my efforts

Gugs Mhlungu is joined by Dr Neelan Pillay, Gynaecologist & Sub-specialist in Reproductive Medicine & Endocrine, discussing the latest advancements in cervical cancer screening including groundbreaking research into using period blood as a potentially accurate and convenient method for detecting early signs of cervical cancer. Gugs Mhlungu gets you ready for the weekend each Saturday and Sunday morning on 702. She is your weekend wake-up companion, with all you need to know for your weekend. The topics Gugs covers range from lifestyle, family, health, and fitness to books, motoring, cooking, culture, and what is happening on the weekend in 702land. Thank you for listening to a podcast from 702 Weekend Breakfast with Gugs Mhlungu. Listen live on Primedia+ on Saturdays and Sundays from 06:00 and 10:00 (SA Time) to Weekend Breakfast with Gugs Mhlungu broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/u3Sf7Zy or find all the catch-up podcasts here https://buff.ly/BIXS7AL Subscribe to the 702 daily and weekly newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

n this episode of the Discover Strength Podcast, CEO and exercise physiologist Luke Carlson breaks down new research on resistance training and fat loss. He reviews a recent study published in Frontiers in Endocrinology and connects it to over a decade of evidence on how strength training influences body composition.Luke explains why the goal of weight loss should be fat loss—not just a lower number on the scale—and how resistance training helps preserve or increase lean muscle while maximizing fat reduction. He also explores the critical role of abdominal fat in cardiometabolic risk and what the latest findings reveal about reducing central obesity.If you want to understand the science behind “high-quality weight loss” and why lifting weights is essential for long-term health and weight maintenance, this episode delivers the key takeaways.Discover Strength offers free Introductory Workouts at any location across the United States. You can schedule your free Introductory Workout HERE !

In this episode, I sit down with Josh Wageman, PhD, DPT, MPAS, CLS, CSCS — Clinical Lipid Specialist, PA who formerly practiced in Endocrinology, and Medical Science Liaison — to explore the intersection of protecting your healthspan while building wealth and expanding career flexibility as a physician associate. Josh's PhD research focused on cholesterol disturbances in Alzheimer's disease, and he's widely known for his ability to teach complex lipid physiology in a relatable, practical way. We break down cholesterol and cardiovascular risk without the overwhelm, discussing which labs and screening strategies are truly worth the cost and effort — and when age or family history should factor into the decision. He also shares what inspired him to write The Home Security System and the Lipid Neighborhood, how writing can serve as both education and diversified income while having a meaningful impact, and why clinicians don't have to feel boxed into a single career path. From becoming a Medical Science Liaison (MSL) to building credibility beyond the clinic, this episode highlights how health, impact, and optionality can work together. If you've ever wondered how to better understand cholesterol, prevent heart attacks, strokes, and dementia, or expand your career beyond traditional clinical roles, this conversation is for you. Get your copy of Josh's book: https://amzn.to/4rYcpoz Connect with Josh on LinkedIn: https://www.linkedin.com/in/josh-wageman-48893445/ Connect with Josh on X: @JoshJWageman Check out Josh's website: lifelovelipids.com If this episode was helpful, subscribe to the PA the FI Way podcast or YouTube channel for more content to help you build financial independence and prevent burnout along the way. Are you just beginning your journey to financial independence and want to learn more? Download your free copy of the PA the FI Way Beginner's Workbook here! Website / Blog: pathefiway.com Follow PA the FI Way on Instagram: @pathefiway https://www.instagram.com/pathefiway/ Connect with Kat on LinkedIn: https://www.linkedin.com/in/katarina-kat-astrup-mspas-pa-c-175848255/ Watch on Youtube: https://www.youtube.com/@pathefiway Join the private Facebook group created for current and future PAs on their journey to financial independence: https://www.facebook.com/groups/pathefiway Like the Facebook page to follow along for updates: https://www.facebook.com/pathefiway Keywords: physician associate, physician assistant, PA, PA-C, MSL, medical science liaison, non-clinical medical roles, non-clinical roles, cardiovascular screening, medical author

With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast. The Points of CARE, the official podcast of Diabetes, Obesity, and Cardiometabolic CARE, will highlight key research findings, clinical implications, and emerging themes across diabetes, obesity, and cardiometabolic health through interviews with journal authors and subject-matter experts. In this special inaugural episode, host Richard Beaser, MD also discusses the ADA's Obesity Association and the "Standards of Care in Overweight and Obesity." 4:15 Beaser speaks with Alissa Segal, PharmD, RPh, CDCES, CDTC, FCCP. Dr. Segal is editor in chief of Diabetes, Obesity, and Cardiometabolic CARE and professor of pharmacy practice at the Massachusetts College of Pharmacy and Health Sciences. Her editorial, "Diabetes, Obesity, and Cardiometabolic CARE: Building New From a Strong Foundation," is available for free at doi.org/10.2337/doci25-0010. 13:00 Samar Hafida, MBCCh, joins the conversation. Dr. Hafida is a board-certified endocrinologist and weight management specialist at Boston Medical Center and assistant professor of medicine (Endocrinology, Diabetes, Nutrition & Weight Management) at the Boston University Chobanian & Avedisian School of Medicine. She is also vice president of the ADA's Obesity Association. Her editorial, "Introducing the Obesity Association and the Launch of Our Official Journal," is available for free at doi.org/10.2337/doci25-0012. 17:55 Dr. Hafida discusses "Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity." This article is available for free at doi.org/10.2337/doci25-0008. 20:05 Richard and Alissa highlight a few articles from the first issue of Diabetes, Obesity, and Cardiometabolic CARE. Simpkins et al. "Association of Type 2 Diabetes Subgroups With Incident Peripheral Neuropathy" doi.org/10.2337/doc25-0051 Livingston et al. "The Benefits and Costs of Treating Obesity Among Adults in the Medicaid Program" doi.org/10.2337/doci25-0005. Davidson et al. "Effectiveness of Using Patient-Defined Meal Sizes to Determine Bolus Doses of Insulin" doi.org/10.2337/doc25-0018 Ali et al. "Patterns of Prescription Discontinuation, Reinitiation, and Switching of Subcutaneous Semaglutide and Tirzepatide in Adults With Obesity" doi.org/10.2337/doc25-0026 Masiano et al. "Type 2 Diabetes Treatment and Experience With Hospitalization in Older Adults: A Convergent Mixed-Methods Study" doi.org/10.2337/doc25-0009 Young et al. "The Critical Role of Diabetology Pharmacists in Improving Cardiovascular-Kidney-Metabolic Care and Outcome" doi.org/10.2337/doc25-0049 To learn more about Diabetes, Obesity, and Cardiometabolic CARE please visit diabetesjournals.org/docm-care. Thank you for listening, and don't forget to subscribe.

Have you longed to integrate your Christian faith into your patient care—on the mission field abroad, in your work in the US, and during your training? Are you not sure how to do this in a caring, ethical, sensitive, and relevant manner? This “working” session will explore the ethical basis for spiritual care and provide you with professional, timely, and proven practical methods to care for the whole person in the clinical setting. https://www.dropbox.com/scl/fi/qpah9kh1lttg6cm1jjop9/Bob-Mason-Ethics-of-Spiritual-Care-revised.pptx?rlkey=0emve2ja8282nv8xc4uinq1hg&st=9033htwx&dl=0

You've treated the pain. You've tracked the triggers. You've adjusted food, sleep, and stress and yet migraines keep finding a way in.What if the missing piece isn't in your head… but in your metabolism?In this episode of Migraine Heroes Podcast, host Diane Ducarme explores one of the most overlooked drivers of migraine: the thyroid. Not as a single lab value, but as a system that sets the rhythm for your brain, your nervous system, and your tolerance to pain.The thyroid doesn't just influence weight or energy. It acts as a metabolic pacemaker, shaping blood flow, heat production, neurotransmitter balance, and stress resilience. When that rhythm slows or becomes unstable, the migraine brain becomes far more reactive — even to triggers that once felt manageable.Blending modern neuroscience with an Eastern medicine lens, this episode unpacks why migraines often show up alongside fatigue, coldness, brain fog, pressure headaches, and that persistent feeling of running on empty.In this episode, you'll learn:Why the thyroid functions as the metabolic pacemaker for the brain and how a slowed rhythm lowers your migraine thresholdHow reduced internal “fire” contributes to dampness, heaviness, and pressure in the headFive subtle yet powerful ways a struggling metabolism signals the nervous system to trigger migraineWhy thyroid-linked migraines often feel slower, heavier, and harder to shakeHow restoring rhythm, warmth, and flow can change how your migraine brain respondsThis episode isn't about diagnosing disease or blaming a single gland. It's about understanding the deeper patterns your body is communicating and responding before those whispers become pain.If your migraines come with fatigue, cold sensitivity, brain fog, or a sense that your system just can't keep up anymore, this conversation may finally bring clarity.

Guidance and key skeletal growth signs that signal the need for a pediatric endocrinology referral. Learn more about pediatric endocrinology at Children's Health.  Learn more about Dr. Merchant.  

Those who hope to honor God and advance Jesus' Kingdom face powerful opposition from spiritual, physical, and psychological enemies. Successful launching and long term fruitfulness depends on recognizing and, in dependence on the Holy Spirit, waging war against those enemies.

Ozempic promete hacerte perder peso rápido.Pero casi nadie te explica qué le está pasando realmente a tu cuerpo mientras lo usas.Hoy te explico qué dice la ciencia de verdad sobre Ozempic, Wegovy y Mounjaro: cómo funcionan, qué efectos tienen realmente, qué riesgos existen, cuándo NO deberías usarlos y por qué perder peso rápido no siempre significa mejorar tu salud.En este vídeo aprenderás:• Qué es Ozempic y cómo actúa en tu cerebro y tu apetito• Cuánto peso se pierde realmente según los estudios• Efectos secundarios frecuentes: náuseas, vómitos, problemas digestivos• Riesgo de pérdida de masa muscular (y por qué eso empeora tu metabolismo)• Problemas de vesícula y pérdida rápida de peso• Advertencia sobre tumores tiroideos observados en animales• Cuándo NUNCA deberías usarlo• En qué casos médicos extremos podría tener sentido• Y la alternativa real: hábitos que funcionan sin depender de fármacosSi estás pensando en usar Ozempic para adelgazar, mira este vídeo antes de tomar una decisión.Si te gusta el contenido claro, basado en ciencia, suscríbete al canal y activa la campanita.Déjame en comentarios tu opinión: ¿usarías Ozempic o prefieres cambiar hábitos?

We have a great show planned today and will talk about why there has been a significant rise in people of all ages using Creatine. To help us unpack all the research and studies we have Dr. Stengler joining us today.In addition to authoring 30 books on health and several best-sellers such as “The Natural Physician's Healing Therapies,” “Prescription for Natural Cures,” “Prescription for Drug Alternatives,” and “Outside the Box Cancer Therapies,” Dr. Stengler has been published in several peer-reviewed medical journals such as The International Journal of Family & Community Medicine, Endocrinology & Metabolism International Journal, and Journal of Nutritional Health & Food Engineering.Dr. Stengler's, NMD. The newest book is called, The Holistic Guide to Gut Health.A comprehensive yet accessible approach to healing leaky gut and the many uncomfortable symptoms it causes. Dr Stengler is also the founder of The Stengler Center for Integrative Medicine.Talking Points:Is creatine only useful for resistance / power type activities?There are a variety of athletic events, not just resistance/power activities, which may benefit from creatine supplementation.-Creatine supplementation with carbohydrate or carbohydrate and protein has been reported to promote greater muscle glycogen storage than carbohydrate supplementation alone.-May reduce muscle damage and/or enhance recovery from intense exercise.-Individuals supplementing their diet with creatine experienced less muscle damage, inflammation, and muscle soreness in response to running 30-km as well as during 4-weeks of intensified training.-There is evidence that athletes who supplement with creatine during training experience fewer musculoskeletal injuries, accelerated recovery time from injury and less muscle atrophy after immobilization.-Creatine supplementation (with or without glycerol) has been reported to help athletes hyper-hydrate and thereby enhance tolerance to exercise in the heat-There is evidence from animal models that creatine supplementation is neuroprotective and can reduce the severity of spinal cord injury, cerebral ischemia, and concussion/traumatic brain injury. This evidence was so compelling that the International Society of Sports Nutrition recommended that athletes engaged in sports that have a potential for concussion and/or spinal cord injury take creatine for its neuroprotective effects.Learn more about Dr. StenglerLearn more about Emerald Labs Creatine Health

Medical missionaries often feel powerful emotional burden from moral injury, and it is a leading cause of departure from the mission field. But we have learned proven methods of preventing and dealing with moral injury. Use God’s powerful methods to protect yourself and your team, and to grow in wisdom and spirit!

HEALTH NEWS   Wild Blueberries May Benefit the Heart, Metabolism, and Microbiome Nitrate in drinking water linked to increased dementia risk while nitrate from vegetables is linked to a lower risk, researchers find   Afternoon naps clear up the brain and improve learning ability Screen time may increase body fat in children Simple dietary change may slow liver cancer in at-risk patients Wild Blueberries May Benefit the Heart, Metabolism, and Microbiome University of Maine & Florida State University, January 28, 2026 (SciTech Daily) A newly published scientific review brings together a growing body of research on how wild blueberries may influence cardiometabolic health. This area of health includes measures such as blood vessel function, blood pressure, blood lipids (cholesterol and triglycerides), and blood sugar (glucose). The review was developed following an expert symposium. Twelve specialists took part, representing fields that included nutrition, food science, dietetics, nutrition metabolism and physiology, cardiovascular and cognitive health, gut health and microbiology, and preclinical and clinical research models.  The paper evaluates findings from 12 human clinical trials conducted over 24 years across four countries that examined the cardiometabolic effects of wild blueberries. Across the clinical research examined, improvements in blood vessel function stand out as one of the most reliable findings. Studies included in the review suggest that wild blueberries may support endothelial function (or how well blood vessels relax and respond to stimuli). Some trials reported effects within hours of a single serving, while others observed benefits after consistent intake over weeks or months. In one six-week clinical study highlighted in the review, adults who consumed 25 grams of freeze-dried wild blueberry powder each day showed increases in beneficial Bifidobacterium species. The authors identify the gut microbiome as a likely contributor to the cardiometabolic effects linked to wild blueberries. The review also suggests wild blueberry intake may support certain aspects of cognitive performance. Improvements were observed in measures such as thinking speed and memory. Several of the reviewed studies reported clinically meaningful improvements in blood pressure, blood sugar regulation, and lipid markers, including total cholesterol, LDL cholesterol, and triglycerides, after weeks of wild blueberry consumption.   Nitrate in drinking water linked to increased dementia risk while nitrate from vegetables is linked to a lower risk, researchers find   Edith Cowan University (Australia) &  Danish Cancer Research Institute, January 28 2026 (Eurekalert) New research from Edith Cowan University (ECU) and the Danish Cancer Research Institute (DCRI) investigated the association between the intake of nitrate and nitrite from a wide range of different sources, and the associated risk of dementia.  The research, which investigated the association between source-specific nitrate and nitrite intake and incident and early-onset dementia, followed more than 54,000 Danish adults for up to 27 years and found that the source of nitrate was of critical importance in a diet.  The researchers found that people who ate more nitrate from vegetables had a lower risk of developing dementia, while those who consumed more nitrate and nitrite from animal foods, processed meats, and drinking water, had a higher risk of dementia.  When we eat nitrate-rich vegetables, we are also eating vitamins and antioxidants which are thought to help nitrate form the beneficial compound, nitric oxide, while blocking it from forming N-nitrosamines which are carcinogenic and potentially damaging to the brain.  Unlike vegetables, animal-based foods don't contain these antioxidants. In addition, meat also contains compounds such as heme iron which may actually increase the formation of N-nitrosamines. This is why nitrate from different sources may have opposite effects on brain health.   This is the first time that nitrate from drinking water has been linked to higher risks of dementia. The study found that participants exposed to drinking-water nitrate at levels below the current regulatory limits, had a higher rate of dementia.   Water doesn't contain antioxidants that can block formation of N-nitrosamines. Without these protective compounds, nitrate in drinking water may form N-nitrosamines in the body.   Afternoon naps clear up the brain and improve learning ability University of Freiburg (Germany) & University of Geneva, January 28 2026 (Eurekalert) Even a short afternoon nap can help the brain recover and improve its ability to learn. In a study published  in the journal NeuroImage, researchers at the  University of Freiburg and the University of Geneva show that even a nap is enough to reorganize connections between nerve cells so that new information can be stored more effectively.  The new study shows that a short sleep period can relieve the brain and put it back into a state of readiness to learn – a process that could be particularly beneficial for situations with high work load. The study examined 20 healthy young adults who either took a nap or stayed awake on two afternoons. The afternoon nap lasted on average 45 minutes.  The results showed that after the nap, the overall strength of synaptic connections in the brain was reduced – a sign of the restorative effect of sleep. At the same time, the brain's ability to form new connections was significantly improved. The brain was therefore better prepared for learning new content than after an equally long period of wakefulness. Screen time may increase body fat in children Ningbo University (China), January 15 2026 (News-Medical) A study published in Frontiers in Endocrinology reveals that higher screen time is associated with higher levels of body fat accumulation and less favorable obesity-related metabolic indicators in school-aged children, and that cardiorespiratory fitness can significantly influence this association. The study included a total of 1,286 third-grade students from six schools in Ningbo. Participants' cardiorespiratory fitness was assessed using the 20-meter shuttle run test. Information on screen time, physical activity, and diet quality was obtained from self-reported questionnaires. The study analysis indicated that higher screen time is significantly associated with increased visceral fat accumulation, body fat mass index, and body fat percentage, and with lower cardiorespiratory fitness and slightly lower blood levels of HDL-C. The study found that participants with more than two hours of daily screen time exhibit significantly increased visceral fat, fat mass index, and fat percentage, and significantly reduced cardiorespiratory fitness compared to those with less than two hours of daily screen time. Simple dietary change may slow liver cancer in at-risk patients Rutgers University, January 29 2026 (Medical Xpress) People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A Rutgers-led study has found that low-protein diets slowed liver tumor growth and cancer death in mice, uncovering a mechanism by which a liver's impaired waste-handling machinery can inadvertently fuel cancer. When people consume protein, the nitrogen can be converted into ammonia, a substance that's toxic to the body and brain. A healthy liver typically processes this ammonia into harmless urea, which is excreted via urine. The clinical observation that the liver's ammonia-handling machinery is usually impaired in liver cancer patients is decades old. Zong's team utilized a technique to induce liver tumors in mice without crippling the ammonia-disposal system. The researchers then used gene-editing tools to disable ammonia-processing enzymes in some—but not all. The results were striking: Mice with disabled enzymes and higher ammonia levels developed heavier tumor burdens and experienced a much faster rate of mortality than those with functioning systems. The researchers then tested a straightforward intervention: reducing dietary protein. Mice fed low-protein food exhibited dramatically slower tumor growth and lived significantly longer than those that received food with standard levels of protein BREAK   Introducing the Clips For Today  Sharmine Narwani : The Slow Strangling of Syria and Lebanon - 4:55  Inventing a pandemic - by Maryanne Demasi, PhD - MD REPORTS - full - 2:49    Did Covid mRNA boosters train the immune system to stand down? - full (Maryanne Demasi)  -2:38   Bryce Nickels on X: "-@R_H_Ebright explains why dangerous gain-of-function research should be BANNED https://t.co/2TaLBzzkU0" / X - full (Richard E Bright explains why dangerous gain of function research should be banned)  - 3:17 

If TikTok influencers are to be believed, testosterone, or T, is the answer to everything from fitness frustrations and fatigue to low libido. But doctors are warning that social media misinformation is driving men to seek testosterone therapy that they don't need. This in turn comes with risks for health and fertility. In part one of a miniseries exploring the popularity of testosterone, Madeleine Finlay hears from Prof Channa Jayasena of Imperial College London, who is chair of the Society for Endocrinology, about how this craze is manifesting in NHS clinics, and from ‘Sam' who tells Madeleine about his own journey with the hormone. Help support our independent journalism at theguardian.com/sciencepod

In this episode, Dr. Jacques Jospitre takes us on a journey through the innovative landscape of mental health care, focusing on the integration of technology at SohoMD. Explore how functional medicine and telehealth are breaking barriers in psychiatry, and learn about the crucial roles of nutrition and endocrinology in mental well-being. Dr. Jospitre emphasizes a holistic approach, merging traditional practices with modern technology to enhance mental health outcomes. Chapters: 00:00:00 Introduction to Dr. Jospitre and Soho MD 00:03:00 The Role of Telehealth in Psychiatry 00:09:00 Integrating Functional Medicine 00:15:00 The Impact of Nutrition and Endocrinology 00:21:00 Talk Therapy and the Power of Belief 00:27:00 Social Media's Influence on Mental Health 00:33:00 Scaling Healthcare with Quality Control 00:39:00 The Future of Holistic Mental Health Care Top Insights: Telehealth removes barriers to accessing mental health care. Functional medicine offers a holistic approach to psychiatry. Nutrition and endocrinology are crucial for mental health. Talk therapy is powerful in shaping beliefs and experiences. The placebo effect highlights the power of belief in treatment. Social media impacts mental health, especially in youth. Quality control is vital when scaling healthcare services. Wearable technology provides valuable data for patient care. Holistic mental health care includes relationships and activity levels. Optimizing mental health requires a comprehensive care team. Join us for this insightful discussion and discover how these advancements are shaping the future of mental health care! Connect with Dr. Jacques Jospitre Wefunder: https://wefunder.com/sohomd LinkedIn: https://www.linkedin.com/in/jospitre/ Website: https://www.sohomd.com/

Guest: Dr. Ehud Ur, Professor of Medicine at the University of British Columbia, Division of Endocrinology and Metabolism Learn more about your ad choices. Visit megaphone.fm/adchoices

Diabetes often develops silently, and by the time symptoms appear, it may have already been there for years. In this episode of Baptist HealthTalk, host Johanna Gomez sits down with Dr. Pascual DeSantis, Chief of Endocrinology, and Dr. Paolo Carvalho, Geriatric and Family Medicine Physician at Baptist Health, to break down what diabetes really is and why so many people miss the early warning signs. The experts explain the differences between type 1, type 2, and pre-diabetes, common symptoms people brush off, and how lifestyle, genetics, and age all play a role. They also discuss what's happening inside the body, why follow-up care matters, and how uncontrolled blood sugar can affect the heart, kidneys, nerves, and vision. Watch now to learn what signs to look for—and when it's time to talk to your doctor.Host:Johanna GomezAward-Winning Host & JournalistGuests:Pascual De Santis, M.D. Chief of Endocrinology Baptist HealthPaulo Carvalho, M.D.Geriatric Medicine & Family Medicine PhysicianBaptist Health Concierge Medicine 

For some people, diabetes can be very hard to control, even with the standard glucose-lowering therapies. Several studies have demonstrated that endogenous hypercortisolism is prevalent among these individuals. What’s the relationship between type 2 diabetes and hypercortisolism, and what do health care providers need to know about that relationship? To help answer those questions, host Aaron Lohr talks with two guests. Vivian A. Fonseca, MD, is a professor of medicine, assistant dean for clinical research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the section of endocrinology at Tulane University Medical Center in New Orleans. James W. Findling, MD, is a professor of medicine and surgery at the Medical College of Wisconsin. Drs. Fonseca and Findling are authors of an article published in the journal Diabetes Care looking at the CATALYST study: “Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.” This episode is made possible by support from Corcept Therapeutics Inc. Show notes are available at https://www.endocrine.org/podcast/enp110 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Dr. Rachel Shell, Riverside Endocrinologist, and Nicole Potts, Registered Dietitian, join us to discuss the Weigh to Healthy Living program, and how it can help participants develop and maintain healthy habits to reach weight management and wellness goals.  Learn more about Rachel Shell, MD 

Host: Darryl S. Chutka, M.D.  Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B.  The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially indicated for management of diabetes, they're frequently taken for the weight loss they commonly produce. How long should these medications be taken? Is there anything we can do to help maintain the weight loss achieved with these medications? How significant is the loss of muscle mass which can occur as part of the weight lost with these medications and can this be minimized. Finally, how safe are the compounded and unapproved versions of these medications patients often find more affordable? These are a few of the questions we'll address in podcast on the GLP-1 medications used for weight loss and we'll tackle the “Controversies and Future of the GLP-1 Medications”. My guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology at the Mayo Clinic.  Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development  Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

In this episode of Health Matters, host Courtney Allison is joined by Dr. Rekha Kumar, endocrinologist and primary care physician at NewYork-Presbyterian and Weill Cornell Medicine, to unpack the science behind aging well. They discuss biohacking, longevity, and health span, separating evidence-based strategies from social media hype and exploring what truly helps us age well.What You'll Learn in This EpisodeWhat “biohacking” really means● How biohacking ranges from simple lifestyle optimization to high-tech, experimental interventions● The difference between lifespan (how long you live) and health span (how long you live well)The Longevity Pyramid● Why the foundation of healthy aging is built on:SleepMovement and strength trainingNutritionStress managementSocial connection● How advanced tools and supplements sit at the top—and why they should never replace the basicsWearables and Tracking● How devices like smartwatches, glucose monitors, and fitness trackers can support behavior change● When tracking becomes counterproductive or stressfulPeptides and “Anti-Aging” Supplements● What's proven (e.g., metformin, GLP-1 receptor agonists)● What's still experimental or under-studied (BPC-157, sermorelin, NAD boosters)Nootropics and Cognitive Enhancers● Everyday nootropics like caffeine● The role of L-theanine for “calm focus”● Myths around perfectly timed caffeine and cortisol rhythmsNutrigenomics and Personalized Nutrition● How genes can influence responses to foods (e.g., lactose intolerance, APOE and saturated fat)● Why many direct-to-consumer genetic tests may overpromiseThe Gut Microbiome● The role of Akkermansia muciniphila in metabolic health● How medications like metformin and GLP-1s may positively shift gut bacteria● What's still unknown about probiotic supplementationGenetic and Biomarker Testing● The difference between actionable medical insights and “information overload”● Why results of unknown significance can cause unnecessary anxietyThe Big Takeaways● There are no true shortcuts to longevity● Sustainable habits beat quick fixes● Our biology is built for rhythms, not constant optimizationFeatured ExpertAbout Rekha B. Kumar, M.D., M.S.Dr. Rekha B. Kumar is an attending endocrinologist at NewYork-Presbyterian/Weill Cornell Medical Center and an associate professor of Clinical Medicine at Weill Cornell Medicine. She specializes in adult primary care and endocrinology and has academic expertise in the diagnosis and treatment of various endocrine disorders, including obesity/weight management, type 2 diabetes, polycystic ovarian syndrome (PCOS), thyroid disorders, as well as metabolic bone disease.Dr. Kumar completed her undergraduate studies at Duke University and received her masters degree in Physiology from Georgetown University. She received her M.D. from New York Medical College and completed her residency training in Internal Medicine at NewYork-Presbyterian/Weill Cornell Medical Center. Dr. Kumar obtained her clinical fellowship in the combined Diabetes, Endocrinology, and Metabolism program at the NewYork-Presbyterian/Weill Cornell Medical Center and the Memorial Sloan Kettering Cancer Center. Dr. Kumar is Board Certified in Internal Medicine, Endocrinology, Diabetes, & Metabolism, and Obesity Medicine.Coming Up NextIn the next episode of Health Matters, we'll explore brain health and the short- and long-term effects of alcohol on the brain with Dr. Hugh Cahill. Subscribe and follow Health Matters on Apple Podcasts, Spotify, or wherever you listen to stay up to date with expert-driven conversations on living well at every stage of life.About Health MattersHealth Matters is your bi-weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org

This is the second of two repeated podcasts that were aired a while ago, which are being re-released. This one with Dr Robert Lustig  was particularly popular with listeners. Dr Robert Lustig  argues sugar is fuelling an epidemic of chronic and metabolic disease, from diabetes and strokes, to cancer and heart disease costing hundreds of thousands of lives. He says in a view that some have seen as controversial that we need to see sugar not just as empty calories,  but as a chronic, addictive toxin. In this podcast, Rob reveals just what sugar does to our bodies. And he claims that while modern medicine has been highly effective in treating acute illness, it has failed in its treatment of chronic conditions, only able to treat the symptoms rather than curing the diseases. In his words: “You can't fix healthcare until you fix health. You can't fix health until you fix diet. And, you can't fix diet until you know what the hell is wrong”. Rob explains what he thinks it is essential to eat to stay healthy  and contends that  prevention is not just better than cure it is the cure.   Dr Robert Lustig is a Professor emeritus of Pediatrics, at the Division of Endocrinology at the University of California, San Francisco. He has written a number of best selling books about the dangers of sugar, refined carbohydrates  and metabolic illness. And his research and clinical practice have focussed on childhood obesity and diabetes. If you would like to support this podcast you can do so via Patreon at or via PayPal. The host of the podcast, Liz Tucker is an award winning medical journalist and former BBC producer and director.  You can follow Liz on X and read further information about the podcast on her Substack newsletter. Medical Matters with Liz Tucker has been selected by Feedspot as one of the top 15 UK Medical Podcasts https://blog.feedspot.com/uk_medical_podcasts/

The endocrine system consists of eight major organs that produce and regulate hormones, the chemical messengers that keep the body in balance. Hormones quietly orchestrate everything from our energy and metabolism to mood, sleep, and resilience, acting as an internal communication network that responds to stress, environment, and lifestyle. From cold plunges and saunas to endocrine-disrupting chemicals, even small daily inputs are said to shift this delicate signaling. How does stress really affect our bodies? Does “adrenal fatigue” exist? Is it actually possible to “biohack” our hormones?In this episode, we are joined by Dr. Priya Jaisinghani, MD, ABIM, DABOM, a triple board-certified Endocrinology, Obesity Medicine, and Internal Medicine physician from New York City.Dr. Jaisinghani received her MD from Rutgers/Robert Wood Johnson Medical School, where she also completed her Internal Medicine Residency, Endocrinology and Obesity Medicine Fellowships at Weill Cornell Medicine. Currently, Dr. Jaisinghani is a Diabetes, Metabolism, and Obesity Medicine attending physician at NYU Langone Health, Clinical Assistant Professor of Medicine at NYU Grossman School of Medicine, and a Medical Unit Contributor at ABC News.Dr. Jaisinghani has been featured on CNN, Rolling Stone, The New York Times, The Wall Street Journal, Men's Health, FOX 5 News, and Medscape,Follow Friends of Franz Podcast: Website, Instagram, FacebookFollow Christian Franz (Host): Instagram, YouTube

Drs Kaniksha Desai and Ralph Tufano discuss nanosecond pulsed field ablation technique. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/index/list_15483_0 Kaniksha Desai, MD, Associate Professor of Medicine, Department of Endocrinology, Stanford School of Medicine, Palo Alto, California Ralph P. Tufano, MD, MBA, Clinical Professor, Department of Otolaryngology-Head and Neck Surgery, Florida State University College of Medicine, Sarasota Memorial Health Care System, Sarasota, Florida

Host: Darryl S. Chutka, M.D. Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B. Using GLP-1 medications for weight loss has become extremely popular. Is this the latest fad in losing weight, or will these medications completely change our approach to managing obesity? They do appear to be very effective in promoting substantial weight loss. What is the history of these medications? Are there differences in the various GLP-1 medications available? What are the potential adverse effects of this drug class? This podcast is the first in a series of three on the GLP-1 medications prescribed for weight loss. The topic for this podcast is “Who Is a candidate for a GLP-1 Medication?” and my guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology and Metabolism at the Mayo Clinic. Check out the series! Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

In recent years, we have seen tremendous growth not just in the popularity of anti-obesity medications, but also in the medications themselves, how effective they are, how many there are. What exactly has changed during this rapid evolution? How safe and effective are these medications today? What challenges still exist in using them? To help answer these questions, host Aaron Lohr speaks with Gitanjali Srivastava, MD, professor of medicine, medical director of Vanderbilt Obesity Medicine, and founding program director of the Obesity Medicine Fellowship at Vanderbilt University Medical Center. Dr. Srivastava presented at the Endocrine Society’s Obesity Fellows Conference in September 2025. The title of her presentation was “Pharmacological Approaches to Treating and Understanding Complicated Obesity.” Listening to this episode can earn you 0.5 ABIM MOC points and 0.5 AMA PRA Category 1 credits. If you are interested in those points and credits, you will need to take a pre-test on the Endocrine Society Center for Learning before listening to this episode. You can find a link in this episode’s show notes. After that pre-test, listen to this episode in the Center for Learning, then take the post-test. This episode is made possible by educational grants from Lilly and Novo Nordisk. Show notes are available at https://www.endocrine.org/podcast/enp109 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Rachel Sachs is a professor of law at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina and R.E. Sachs. Insurance Coverage and Pricing of Weight-Loss Drugs in the United States. N Engl J Med 2026;394:105-107. S. Gondi, A.S. Kesselheim, and B.N. Rome. Generic Liraglutide — Overlooked but Not Forgotten. N Engl J Med. DOI: 10.1056/NEJMp2515668.

In this episode of the Evolving Wellness Podcast, I delve into the complexities of vitamin D and melatonin, particularly during the winter months. I discuss the natural decline of vitamin D levels in winter, the critical role of melatonin, and how modern lifestyles disrupt these hormonal balances. The conversation covers the impact of stress, alcohol, and blue light on health, the importance of circadian rhythms, and the potential benefits and drawbacks of vitamin D supplementation. Links: Become a substack subscriber & get early access to podcasts + free courses - https://open.substack.com/pub/sarahkleinerwellness/p/uvbred-light-protocol?r=5eztl9&utm_campaign=post&utm_medium=web&showWelcomeOnShare=trueHoliday Sale - https://www.sarahkleinerwellness.com/SKW-holidayFree Webinar - https://www.sarahkleinerwellness.com/mycircadianapp-free-webinarTimestamps:00:00 Introduction to Vitamin D and Melatonin02:47 Understanding Seasonal Changes in Vitamin D Levels06:13 The Role of Melatonin in Winter Health09:00 Impact of Modern Lifestyle on Vitamin D and Melatonin11:51 The Effects of Stress and Alcohol on Hormonal Balance15:08 Circadian Rhythms and Their Importance17:51 The Dangers of Blue Light and Sleep Disruption21:07 Winter Infections and Their Impact on Vitamin D23:59 Pros and Cons of Vitamin D Supplementation27:13 Understanding Individual Variability in Vitamin D Metabolism29:52 Short-Term Vitamin D Supplementation: When Is It Appropriate?33:14 The Importance of Comprehensive Testing and Monitoring36:01 Conclusion and Future DirectionsReferences & further reading:Article: You've been warned about sunlight but not about supplements - http://sarahkleinerwellness.com/blog/you-ve-been-warned-about-sunlight-but-not-supplementsArticle - Can vitamin D supplements lower your melatonin? https://sarahkleinerwellness.substack.com/p/can-vitamin-d-supplements-lower-yourManson et al. VITAL primary outcomes. N Engl J Med. 2019. PMID: 30415629Sanders et al. Annual high-dose D ↑ falls/fractures. JAMA. 2010. PMID: 20157135Bischoff-Ferrari et al. Monthly high-dose D ↑ falls. JAMA Intern Med. 2016. PMID: 26747333Jackson et al. WHI Ca+D ↑ kidney stones. N Engl J Med. 2006. PMID: 16481635Slominski et al. Melatonin, mitochondria & skin photobiology. Cell Mol Life Sci. 2020.Hamblin MR. Anti-inflammatory photobiomodulation. AIMS Biophys. 2017.Deng et al. Magnesium, vitamin D status & mortality (NHANES). BMC Med. 2013.Holick et al. Translocation of cutaneous vitamin D₃. Endocrinology. 1994.This video is not medical advice & as a supporter to you and your health journey - I encourage you to monitor your labs and work with a professional!________________________________________Get all my free guides and product recommendations to get started on your journey!https://www.sarahkleinerwellness.com/all-free-resourcesCheck out all my courses to understand how to improve your mitochondrial health & experience long lasting health! (Use code PODCAST to save 10%) - https://www.sarahkleinerwellness.com/coursesSign up for my newsletter to get special offers in the future! -https://sarahkleinerwellness.kit.com/profile?_gl=1*1gs7n29*_gcl_aw*R0NMLjE3NjQwOTIxNjcuQ2owS0NRaUF4SlhKQmhEX0FSSXNBSF9KR2poSEZxTTl0blpDSEl4SjYyRHdpa1FuNGc3QXplVll4NVktSFhmSFZZamEwVDAtcU92YXlfQWFBbHp0RUFMd193Y0I.*_gcl_au*MTgwMTYwMTMxMi4xNzYzMzIwODkyLjYyODE4ODI3NC4xNzY1NTA5NjM3LjE3NjU1MDk2MzY.Free Guide to Building your perfect quantum day (start here) -https://www.sarahkleinerwellness.com/opt-in-9d5f6918-77a8-40d7-bedf-93ca2ec8387fMy free product guide with all product recommendations and discount codes:https://www.canva.com/design/DAF7mlgZpJI/xVyE4tiQFEWJmh_Xwx8Kbw/view?utm_content=DAF7mlgZpJI&utm_campaign=designshare&utm_medium=link2&utm_source=uniquelinks&utlId=h0782b52987

A breakthrough in inflammatory support has arrived in the natural health market. PEA, which stands for palmitoylethanolamide, is a naturally occurring fatty acid derivative made in the body and found in small amounts in foods. Several human studies have demonstrated that PEA has broad- spectrum pain-relieving properties, anti-inflammatory effects, and nerve protection.To help us unpack all the research and studies we have Dr. Stengler joining us today.In addition to authoring 30 books on health and several best-sellers such as “The Natural Physician's Healing Therapies,” “Prescription for Natural Cures,” “Prescription for Drug Alternatives,” and “Outside the Box Cancer Therapies,” Dr. Stengler has been published in several peer-reviewed medical journals such as The International Journal of Family & Community Medicine, Endocrinology & Metabolism International Journal, and Journal of Nutritional Health & Food Engineering.Dr. Stengler's, NMD. The newest book is called, The Holistic Guide to Gut Health. A comprehensive yet accessible approach to healing leaky gut and the many uncomfortable symptoms it causes. Dr Stengler is also the founder of The Stengler Center for Integrative Medicine.Talking Points:Palmitoylethanolamide (PEA), is a naturally occurring fatty acid derivative made in the body and found in small amounts in foods. PEA was first discovered in 1957 by scientists at Merck Sharp & Dohme, who isolated it from egg yolk, peanut meal, and soy lecithin. They found that PEA had anti-inflammatory properties in guinea pigs.However, PEA's role as a potential therapeutic agent was not widely recognized until 1993, when Rita Levi-Montalcini and her colleagues published research that suggested PEA has anti-inflammatory properties. Levi-Montalcini's group termed PEA an autocoid local injury antagonist (ALIA), and suggested that it acts locally to counteract injury.Multiple studies have demonstrated that PEA improves all sorts of pain. For example, a 2023 analysis of 11 studies found that PEA improved pain of various conditions, including muscle and joints, nerves, gynecological, and digestive. In terms of joint pain, a high-quality study demonstrated that PEA significantly reduced adult joint pain compared to placebo. Moreover, 8 clinical trials demonstrated that PEA was effective for low back pain, sciatica, and carpal tunnel syndrome. Even migraine headache pain was shown in published research to be improved with PEA.Lipid mediators help to balance the immune, nervous, and endocrine systems, affecting pain pathways related to inflammation. But unfortunately, due to changing diets, many of us do not get the nutrition and activity we need to make enough PEA ourselves.Supplemental PEA, by Levagen+ is properly formulated for optimal bioavailability, 75% more bioavailable to cell receptors than dietary forms. Levagen+ liposomal delivery of PEA has been clinically studied and shows benefits in joint pain, nerve pain, migraine, infections, sleep, and cognitive function.Learn more about Dr. Mark Stengler, NMDLearn more about Emerald Labs PEA+ Levagen Use the code: Forever and get 20% off your order.

Welcome to the emDOCs.net podcast! Join us as we review our high-yield posts from our website emDOCs.net.Today on the emDOCs cast with Brit Long (@long_brit), we cover metformin toxicity.To continue to make this a worthwhile podcast for you to listen to, we appreciate any feedback and comments you may have for us. Please let us know!Subscribe to the podcast on one of the many platforms below:Apple iTunesSpotifyGoogle Play 

What is a call? How does a person know if God is calling them to mission service? Join in a discussion as these and other questions are addressed.

In the last five years, the field of artificial intelligence and robotics has taken off and has become a part of our everyday life, and it continues to grow and evolve. How are AI and robotics shaping the field of medicine? How is it improving the lives of doctors and patients? We used to ask, “What is the role of AI in medicine?” Are we getting closer to a time where we’ll be asking what the role is of humans? To help us answer these questions, host Aaron Lohr talks with Hassan M. Heshmati, MD. Dr. Heshmati has been a physician for 49 years and an endocrinologist for 45 years, with experience in clinical research and academia and in the pharmaceutical biotech industry. He founded Endocrinology Metabolism Consulting, based in Anthem, Ariz., and presented an abstract at ENDO 2025 titled, “Update on the Use of Robotic Surgery and Artificial Intelligence for Adrenal Tumors.” Show notes are available at https://www.endocrine.org/podcast/enp108 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Low resource settings require much innovation and streamlining resources to meet set goals. With healthcare becoming more commercial and profit driven, missional healthcare in low resource settings faces many challenges. Sustainability is a big question with people finance , and equipment scarce and hard to come by. Missional models of healthcare often run into hurdles of sustainability, longevity and relevance even as healthcare slowly turns into business. In this setting of multifactorial challenges and increasing compliances how can missional healthcare be relevant and sustainable? Many saints of God have committed their lives to fulfil this great commission in some of the most underserved and unreached areas of the world. With the birth of Emmanuel Hospital Association (EHA) a different model of missional healthcare emerged in India. Over the last 55 years of its existence, EHA has shown that through all the challenges, this may be one of the ways to sustain missional healthcare in areas of need. With increasing divide between the rich and poor, overwhelmed government systems, a ruthless insurance system, and high end corporate healthcare, it is still possible for missional healthcare to provide low cost, high quality, technologically advanced care to people in need while remaining sustainable. We bring lessons from India and our experience with Emmanuel Hospital Association over the last 3 decades.

Podcast Family, we have covered PCOS on this show many times in the past; and yet- again, there is new information! A new publication from AJOG (Gray journal) describes a new meta-analysis on preconception/continued metformin use in the first trimester. Is this helpful? How does this contrast with the 2023 international guidance update on PCOS? Listen in for details. 1. ASRM: Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023)2. Cheshire J, Garg A, Smith P, Devall AJ, Coomarasamy A, Dhillon-Smith RK. Preconception and first-trimester metformin on pregnancy outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025 Dec;233(6):530-547.e8. doi: 10.1016/j.ajog.2025.05.038. Epub 2025 Jun 3. PMID: 40473092.3. Løvvik TS, Carlsen SM, Salvesen Ø, et al. Use of Metformin to Treat Pregnant Women With Polycystic Ovary Syndrome (PregMet2): A Randomised, Double-Blind, Placebo-Controlled Trial. The Lancet. Diabetes & Endocrinology. 2019;7(4):256-266. doi:10.1016/S2213-8587(19)30002-6.4. Teede HJ, Tay CT, Laven J, et al. Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility. 2023;120(4):767-793. doi:10.1016/j.fertnstert.2023.07.025.

Join Dr. Steven Petak, Past President of AACE and ISCD and former Chief of Endocrinology at Houston Methodist Hospital, as he leads an in-depth conversation on Hypophosphatemia with Dr. Laila Tabatabai, Associate Professor of Clinical Medicine at Weill Cornell and metabolic bone specialist at Houston Methodist, and Dr. Basma Abdulhadi, Assistant Professor of Medicine at the University of Alabama at Birmingham and head of bone densitometry. Together, they discuss how to distinguish Hypophosphatemia from osteoporosis and osteomalacia, recognize key symptoms across ages, and apply a focused diagnostic workup. The discussion also highlights FGF23-mediated disorders, XLH, and current treatment approaches including burosumab, reinforcing a key reminder for clinicians to check phosphate levels to help prevent missed diagnoses. This episode is made possible through a sponsorship from Kyowa Kirin.Kyowa Kirin was not involved in the content of the podcast.

On this episode, Isaac Sachmechi, MD, Endocrinology, Diabetes, and Metabolism, Internal Medicine at NYC Health + Hospitals/Queens joins the podcast to discuss why NYC Health + Hospitals/Queens is recognized for excellence in diabetes care. He shares insights into the future of diabetes treatment, highlights advancements in care delivery, and explores strategies for improving patient outcomes in endocrinology.

With updated thyroid cancer guidelines, adjunct diagnostic and treatment tools, and growing interest in minimalist approaches, it is increasingly challenging to know the optimal management for patients with small, differentiated thyroid cancer including when to refrain from operating. In this episode, we discuss the nuanced decision making in managing these patients, the multiple factors that are taken into consideration, and strategies in conducting efficacious conversations with patients. Hear from our world-renowned expert panel, Dr. Michael Tuttle, Professor and Chief of Endocrinology at Memorial Sloan Kettering Cancer Center, and Dr. Douglas Fraker, The Jonathan Rhoads Professor of Surgery Emeritus at the University of Pennsylvania , moderated by Dr. Mahsa Javid, Endowed Chair in Endocrine Surgery.

Drs Kaniksha Desai and Whitney Goldner discuss a new guideline approach for active surveillance for selected patients with low-risk papillary thyroid cancer. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/index/list_15483_0 Kaniksha Desai, MDAssociate Professor of Medicine, Department of Endocrinology, Stanford School of Medicine, Palo , Whitney S. Goldner, MD, Professor; Head, Department of Internal Medicine, Division of Diabetes, Endocrinology, and Metabolism, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado

We welcome Dr. Pasquale Passarella, an endocrinologist at Albany Med. Ray Graf hosts.

Join Dr. Bahar Force, Endocrinologist, Medical Director of the Pituitary Center, and Associate Program Director of the Endocrinology Fellowship Program at Baylor College of Medicine, as she speaks with leading experts Dr. James Findling, Clinical Professor of Endocrinology at the Medical College of Wisconsin, and Dr. Ty Carroll, Visiting Professor of Endocrinology and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Wisconsin Madison, for a clinician-focused conversation on non-neoplastic hypercortisolism. Together, they discuss how common conditions can lead to cortisol elevations that resemble Cushing syndrome, the clinical patterns that raise concern for neoplastic hypercortisolism, and the growing role of the Desmopressin Stimulation Test in helping distinguish between the two. The episode also highlights emerging research, including insights from the Catalyst study and the potential role of cortisol-directed therapy. 

Technically known as glucagon-like peptide-1 receptor agonists, or GLP-1, these drugs have been around for years for treating diabetes. Now it seems most people think of GLP-1 drugs as medications to lose weight, and these medications are so popular that for a time, supply could not meet demand, leaving many to seek compounded GLP-1 medications, which were more accessible and affordable. However, compounded medications are not FDA-approved, and there are questions regarding their safety and efficacy. What do doctors and patients need to know when considering using compounded obesity medications? To help answer this, host Aaron Lohr talks with Michael Weintraub, MD, an endocrinologist at NYU Langone Division of Endocrinology. Dr. Weintraub serves on the exam writing committee for the American Board of Obesity Medicine. Support for this episode was provided by Lilly. Show notes are available at https://www.endocrine.org/podcast/enp107 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

This episode covers early puberty.Written notes can be found at https://zerotofinals.com/paediatrics/development/earlypuberty/Questions can be found at https://members.zerotofinals.com/Books can be found at https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

In this episode, Dr. Andrea Rosen, a first-year endocrinology fellow at UVMMC, opens with a rapid-fire endocrine round, from her favorite organ and go-to hormone excuse to T3 vs. T4, metformin's true identity, and endocrinology in five words. She then shares what inspired her to pursue medicine, the biggest learning curves of her first fellowship year, and the moments that reaffirmed her choice of endocrinology. Dr. Rosen also offers advice for trainees considering the field and reflects on where she hopes to take her career next.   Co-Hosts: Caity Decara: caitlin.decara@med.uvm.edu Haley Bayne: haley.bayne@med.uvm.edu

In this episode of Molecule to Market, your host Raman Sehgal discusses the pharmaceutical and biotechnology supply chain with Jean-François Brepson, Chief Executive Officer at PathoQuest. The conversation covers: Navigating 20 years of global leadership roles at Ipsen before moving from the corporate world into an investor-led entrepreneurial adventure The tough decision to refocus PathoQuest from diagnostics into a pure play CRO and pharma services business How a major strategic partnership transformed the company's trajectory and why Jean sees partnerships as a competitive weapon Riding the tailwind of the FDA's move away from animal testing and offering something game-changing in the CMC and GMP space The opportunities ahead for CROs and CDMOs in helping unlock the next wave of innovation Jean-François Brepson is a dedicated leader with deep experience in biotechnology and pharmaceuticals. Since becoming CEO of PathoQuest in 2015, he has built the company into a leading global CRO specializing in quality control of biological drugs using Next Generation Sequencing (NGS). Over his career, he has advanced innovative technologies and solutions that bridge scientific progress with real-world application. Prior to joining PathoQuest, Jean was Senior Vice President at Ipsen, where he led the global GI-Oncology and Endocrinology franchise.   Molecule to Market is sponsored by Bora Pharma, Charles River, and Lead Candidate. Please subscribe, tell your industry colleagues, and help us celebrate the value of the global life science outsourcing space. We'd also appreciate a positive rating!

What role does thyroid artery embolization play in contemporary thyroid cancer care? Dr. Juan Camacho, an interventional radiologist from Sarasota, Florida, joins host Dr. Sabeen Dhand to discuss how this emerging technique is reshaping the management of thyroid malignancies. --- SYNPOSIS Dr. Camacho shares his experiences establishing a multidisciplinary team at Memorial Sloan Kettering Cancer Center dedicated to the management of thyroid malignancies, highlighting the critical role of collaboration in the successful implementation of this emerging treatment. He details key procedural techniques, emphasizing the importance of recognizing anatomic variations that can influence technical success. He also examines how arterial supply and lesion location inform procedural planning and decision-making, and outlines his technical approach to thyroid artery embolization, including the use of a radial artery access, catheter selection strategies, and the application of cone-beam CT for procedural optimization. Finally, he reviews his pre- and post-procedural management strategies, including the role of beta blockers in optimizing patient outcomes. The discussion concludes with illustrative case studies demonstrating substantial reductions in thyroid volume and symptomatic relief, notably achieved without post-procedural hypothyroidism. --- TIMESTAMPS 00:00 - Introduction03:31 - Pioneering Thyroid Ablation at Sloan Kettering06:53 - The Need for Thyroid Artery Embolization25:08 - Pre-Procedural Planning32:41 - Embolization Technique and Procedure44:48 - Choosing the Right Catheter for the Job45:43 - Ensuring Patient Comfort and Safety47:09 - High-Stakes Imaging and Safety Protocols47:55 - Innovative Techniques and Case Studies51:02 - Post-Procedure Management and Follow-Up56:30 - Engaging with Endocrinology and Surgeons01:00:00 - Case Studies and Practical Applications